Featured Posts
National Review
Prescription Drugs Save Lives at a (Mostly) Reasonable Cost
Prescription drugs are an extraordinary lifesaving and life-enhancing technology, so integrated into our daily lives that, nowadays, we perhaps take them for granted. Headlines and…
News Release
FDA deserves credit for approval pancreatic cancer drug
The FDA on August 26 approved a new breakthrough drug to treat pancreatic cancer. CEI Senior Fellow and Economist Jeremy Nighohossian praised…
Blog
Fauci’s lasting legacy will be the damage he did to science and government
Anthony Fauci isn’t faring well in the court of public opinion. His recently divulged “diary” and subsequent July 29 appearance before the Senate Homeland…
Search Posts
Daily Caller
Regulation Is This Halloween’s Goblin
American entrepreneurs and small business owners have good reason to be scared this Halloween. According to a new Gallup poll, small business owners consider…
Comment
CEI Comments to the Food and Drug Administration Regarding Medical Device Regulation
Full Document Available in PDF The Competitive Enterprise Institute appreciates the opportunity to submit these comments regarding…
Comment
CEI Comments to the Food and Drug Administration Regarding PDUFA Reauthorization
Full Document Available in PDF The Competitive Enterprise Institute appreciates the opportunity to submit these comments regarding…
Daily Caller
Seeing Double Regulation
When asked to name the most controversial medical issues of the day, few people would pick eye care. However, in the past half-century, eye…
Daily Caller
Weekend Reading: The True Story of Cosmetics
Daily Caller